DekaBank Deutsche Girozentrale - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,043,000
+72.1%
100,000
+92.7%
0.00%
+50.0%
Q2 2022$606,000
+24.9%
51,9000.0%0.00%
+100.0%
Q1 2022$485,000
-38.3%
51,900
+1.4%
0.00%
-50.0%
Q4 2021$786,000
-38.8%
51,200
+2.6%
0.00%
-50.0%
Q3 2021$1,284,000
+2.1%
49,9000.0%0.00%0.0%
Q2 2021$1,257,000
-24.6%
49,9000.0%0.00%
-33.3%
Q1 2021$1,668,000
+34.8%
49,900
+8.7%
0.01%
+20.0%
Q4 2020$1,237,000
-20.4%
45,900
+11.4%
0.01%
-28.6%
Q3 2020$1,554,000
+773.0%
41,200
+509.3%
0.01%
+600.0%
Q4 2019$178,0006,7620.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders